Item 1. Security and Issuer.
This joint statement on Schedule 13D (this “Statement”) is filed with respect to the Common Stock, par value $0.0001 per share (“Common Stock”), of Amprius Technologies, Inc., a Delaware corporation (the “Issuer”). The address of the principal executive offices of the Issuer is 1180 Page Ave, Fremont, California 94538.
Item 2. Identity and Background.
(a) This Statement is being filed by Trident Capital Management – VI, L.L.C. (“TCM VI”), Trident Capital Fund – VI, L.P. (“Trident Fund VI”), Trident Capital Fund – VI Principals Fund, L.L.C. (“Trident Principal VI”, together with TCM VI and Trident Fund VI, the “Reporting Entities”) and Donald R. Dixon, a member of the Issuer’s board of directors (the “Board”), and John H. Moragne (together with Mr. Dixon, the “Managing Members”). The Reporting Entities and the Managing Members are collectively referred to as the “Reporting Persons.” The agreement among the Reporting Persons to file jointly in accordance with the provisions of Rule 13d-1(k)(1) under the Act is attached hereto as Exhibit 1. Each Reporting Person disclaims beneficial ownership of all securities reported in this Statement except to the extent of such Reporting Person’s pecuniary interest therein, other than those securities reported herein as being held directly by such Reporting Person.
(b) The address of the principal offices of each Reporting Entity and the business address of the Managing Members is 404 S El Camino Real # 1050, San Mateo, CA 94402.
(c) Each Reporting Entity is a venture capital investment entity. TCM VI is the sole general partner of Trident Fund VI and the sole managing member of Trident Principals VI. Donald R. Dixon and John H. Moragne are the managing members of TCM VI and, as such, may be deemed to have shared voting and dispositive power with respect to the securities held of record by each of Trident Fund VI and Trident Principals VI.
(d) During the past five years, none of the Reporting Persons have been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).
(e) None of the Reporting Persons are, nor during the last five years have been, a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.
(f) Each of TCM VI and Trident Principal VI is a limited liability company organized under the laws of the State of Delaware. Trident Fund VI is a limited partnership organized under the laws of the State of Delaware. Donald R. Dixon and John H. Moragne are each a citizen of the United States of America.
Item 3. Source and Amount of Funds or Other Consideration.
In February 2009, Trident Fund VI and Trident Principals VI purchased an aggregate of 4,552,352 shares of the Series A preferred stock of Amprius, Inc. (“Amprius Holdings”) at a purchase price of $0.4631 per share and an aggregate purchase price of approximately $2,100,000.
In March 2010, Trident Fund VI and Trident Principals VI purchased an aggregate of 541,947 shares of Amprius Holdings’ Series A preferred stock at a purchase price of $0.4631 per share and an aggregate purchase price of approximately $250,000.
In February 2011, Trident Fund VI and Trident Principals VI purchased an aggregate of 3,300,638 shares of Amprius Holdings’ Series B preferred stock at a purchase price of $1.3562 per share and an aggregate purchase price of approximately $4,476,325.
In February 2011, Mr. Dixon purchased 184,338 shares of Amprius Holdings’ Series B preferred stock at a purchase price of $1.3562 per share and an aggregate purchase price of approximately $249,999.